NM-aFGF can then inhibit myocardial oxidative stress damage due to DM by activating the AKT/GSK/Nrf-2 signaling pathway, thus improving myocardial structural and functional lesions in diabetic rats. Here, AKT1 is linked to diabetes mellitus.